A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

NCT02354586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

463

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Ovarian Cancer

Interventions

DRUG: Niraparib

Sponsor

Tesaro, Inc.

Collaborators

[object Object]
[object Object]